dr. mok discusses developing lung cancer treatments
Published 10 years ago • 341 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:38
dr. mok on improving lung cancer drug development
-
0:44
dr. mok on dacomitinib for first-line lung cancer treatment
-
2:12
dr. mok discusses updated data with pembrolizumab in nsclc
-
1:02
dr. mok on overall survival data from the alex trial in alk lung cancer
-
0:49
dr. mok on plasma testing in lung cancer
-
1:38
dr. mok discusses next steps for pembrolizumab in nsclc
-
1:18
dr. mok on breakthrough therapies for alk-positive nsclc
-
0:59
dr. mok gives an overview of plasma testing approaches for lung cancer
-
1:53
dr. mok on the utility of afatinib in lung cancer
-
2:03
dr. yang discusses the future of lung cancer treatment
-
5:01
chemotherapy-tki combinations in metastatic egfr lung cancer
-
3:31
the evolution of alk/ros1-targeted tkis
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
8:55
choosing second-line therapy for alk nsclc
-
0:32
dr. hak choy on radiation and immunotherapy in combination in lung cancer
-
1:23
dr. roy s. herbst explores molecular testing in lung cancer
-
1:32
dr. roth discusses the treatment of several cancers with bevacizumab
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning
-
1:41
dr. hanna on challenges with consolidation immunotherapy in lung cancer